 Sean Davis
Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Software | 2 | 2016 | 665 | 0.620 |
Why?
| | Genomics | 4 | 2016 | 790 | 0.440 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2016 | 535 | 0.330 |
Why?
| | Neoplasms | 4 | 2016 | 2644 | 0.280 |
Why?
| | Sarcoma, Synovial | 1 | 2007 | 21 | 0.270 |
Why?
| | DNA Copy Number Variations | 3 | 2016 | 182 | 0.250 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2007 | 214 | 0.230 |
Why?
| | Exome | 3 | 2016 | 230 | 0.230 |
Why?
| | Disease Models, Animal | 3 | 2017 | 4281 | 0.160 |
Why?
| | MicroRNAs | 2 | 2016 | 692 | 0.150 |
Why?
| | Point Mutation | 2 | 2016 | 235 | 0.140 |
Why?
| | Polyendocrinopathies, Autoimmune | 1 | 2017 | 18 | 0.140 |
Why?
| | Exons | 2 | 2016 | 351 | 0.130 |
Why?
| | Receptors, Glucocorticoid | 2 | 2009 | 155 | 0.130 |
Why?
| | Enhancer Elements, Genetic | 2 | 2015 | 190 | 0.130 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2017 | 95 | 0.130 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2016 | 20 | 0.130 |
Why?
| | Adenomatous Polyps | 1 | 2016 | 10 | 0.130 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2016 | 34 | 0.120 |
Why?
| | NFI Transcription Factors | 1 | 2015 | 8 | 0.120 |
Why?
| | Genetic Variation | 3 | 2015 | 985 | 0.120 |
Why?
| | Comparative Genomic Hybridization | 1 | 2015 | 30 | 0.120 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2014 | 14 | 0.110 |
Why?
| | Cell Line, Tumor | 8 | 2017 | 3405 | 0.110 |
Why?
| | Osteosarcoma | 1 | 2015 | 74 | 0.110 |
Why?
| | Thyroid Carcinoma, Anaplastic | 1 | 2014 | 34 | 0.110 |
Why?
| | Stomach Neoplasms | 1 | 2016 | 122 | 0.110 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2017 | 247 | 0.110 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2015 | 92 | 0.110 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2015 | 137 | 0.110 |
Why?
| | Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2013 | 11 | 0.110 |
Why?
| | Leukemia, Hairy Cell | 1 | 2013 | 7 | 0.110 |
Why?
| | Mutation Rate | 1 | 2013 | 29 | 0.110 |
Why?
| | Neoplasms, Second Primary | 1 | 2015 | 116 | 0.110 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2013 | 83 | 0.100 |
Why?
| | Interferon Regulatory Factors | 1 | 2013 | 38 | 0.100 |
Why?
| | MAP Kinase Kinase 1 | 1 | 2013 | 75 | 0.100 |
Why?
| | Data Mining | 1 | 2014 | 116 | 0.100 |
Why?
| | Transcription Factors | 3 | 2017 | 1718 | 0.100 |
Why?
| | DNA Methylation | 2 | 2016 | 640 | 0.100 |
Why?
| | Esophageal Neoplasms | 1 | 2017 | 321 | 0.100 |
Why?
| | Databases, Nucleic Acid | 1 | 2013 | 34 | 0.100 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2013 | 194 | 0.100 |
Why?
| | Bone Neoplasms | 1 | 2015 | 247 | 0.100 |
Why?
| | Receptor, ErbB-2 | 1 | 2015 | 340 | 0.100 |
Why?
| | Thyroid Hormone Receptors beta | 1 | 2012 | 1 | 0.100 |
Why?
| | RNA, Messenger | 3 | 2016 | 2831 | 0.090 |
Why?
| | Chromosomes, Human, X | 1 | 2012 | 73 | 0.090 |
Why?
| | Genome | 1 | 2014 | 294 | 0.090 |
Why?
| | DNA, Neoplasm | 1 | 2012 | 164 | 0.090 |
Why?
| | Replication Origin | 1 | 2011 | 19 | 0.090 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2017 | 683 | 0.090 |
Why?
| | Pituitary Gland | 1 | 2012 | 148 | 0.090 |
Why?
| | Osteoblasts | 1 | 2012 | 126 | 0.090 |
Why?
| | Epithelial Cells | 1 | 2017 | 1094 | 0.090 |
Why?
| | Genetic Loci | 1 | 2012 | 288 | 0.090 |
Why?
| | Thyroid Neoplasms | 1 | 2014 | 337 | 0.080 |
Why?
| | Gene Silencing | 1 | 2011 | 195 | 0.080 |
Why?
| | Osteogenesis | 1 | 2012 | 186 | 0.080 |
Why?
| | Wnt Signaling Pathway | 1 | 2012 | 192 | 0.080 |
Why?
| | Genetic Linkage | 3 | 2016 | 297 | 0.080 |
Why?
| | beta Catenin | 1 | 2012 | 253 | 0.080 |
Why?
| | Computational Biology | 1 | 2014 | 643 | 0.080 |
Why?
| | DNA Replication | 1 | 2011 | 238 | 0.080 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2015 | 2184 | 0.080 |
Why?
| | Breast Neoplasms | 2 | 2015 | 2234 | 0.080 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2015 | 1396 | 0.080 |
Why?
| | Genome, Human | 1 | 2011 | 423 | 0.080 |
Why?
| | Adenocarcinoma | 1 | 2016 | 938 | 0.080 |
Why?
| | Transcription, Genetic | 2 | 2015 | 1455 | 0.080 |
Why?
| | Response Elements | 1 | 2009 | 91 | 0.070 |
Why?
| | Gene Expression Regulation | 4 | 2015 | 2605 | 0.070 |
Why?
| | Genome-Wide Association Study | 1 | 2015 | 1428 | 0.070 |
Why?
| | Chromatin | 2 | 2011 | 519 | 0.070 |
Why?
| | Myoblasts, Skeletal | 1 | 2007 | 12 | 0.070 |
Why?
| | Animals | 10 | 2017 | 36823 | 0.060 |
Why?
| | Muscular Diseases | 1 | 2007 | 114 | 0.060 |
Why?
| | Mice | 8 | 2017 | 17733 | 0.060 |
Why?
| | Arthritis, Rheumatoid | 1 | 2015 | 1167 | 0.060 |
Why?
| | Recombinant Fusion Proteins | 1 | 2008 | 664 | 0.060 |
Why?
| | Prostatic Neoplasms | 1 | 2012 | 1034 | 0.060 |
Why?
| | Cell Differentiation | 2 | 2015 | 1982 | 0.060 |
Why?
| | Lung Neoplasms | 1 | 2017 | 2489 | 0.050 |
Why?
| | Humans | 15 | 2017 | 136764 | 0.050 |
Why?
| | Mutation | 2 | 2013 | 3946 | 0.050 |
Why?
| | Nuclear Proteins | 3 | 2013 | 712 | 0.050 |
Why?
| | Gene Expression Profiling | 3 | 2017 | 1772 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 3 | 2015 | 2412 | 0.040 |
Why?
| | Recombination, Genetic | 2 | 2012 | 200 | 0.040 |
Why?
| | Cell Movement | 2 | 2015 | 965 | 0.040 |
Why?
| | Base Sequence | 2 | 2014 | 2179 | 0.040 |
Why?
| | ErbB Receptors | 2 | 2017 | 613 | 0.040 |
Why?
| | Apoptosis | 1 | 2008 | 2551 | 0.040 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2013 | 528 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2017 | 194 | 0.030 |
Why?
| | Candidiasis | 1 | 2017 | 56 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2007 | 1710 | 0.030 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 98 | 0.030 |
Why?
| | Mice, SCID | 1 | 2017 | 366 | 0.030 |
Why?
| | Allelic Imbalance | 1 | 2016 | 9 | 0.030 |
Why?
| | Teratoma | 1 | 2017 | 114 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2009 | 766 | 0.030 |
Why?
| | Gastric Mucosa | 1 | 2016 | 55 | 0.030 |
Why?
| | Loss of Heterozygosity | 1 | 2016 | 51 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2017 | 600 | 0.030 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2015 | 41 | 0.030 |
Why?
| | Mutagenesis, Insertional | 1 | 2015 | 64 | 0.030 |
Why?
| | Carcinogenesis | 1 | 2017 | 217 | 0.030 |
Why?
| | Janus Kinase 3 | 1 | 2015 | 18 | 0.030 |
Why?
| | Adult Survivors of Child Adverse Events | 1 | 2015 | 12 | 0.030 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2015 | 55 | 0.030 |
Why?
| | DNA-Binding Proteins | 2 | 2013 | 1501 | 0.030 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2015 | 41 | 0.030 |
Why?
| | p300-CBP Transcription Factors | 1 | 2015 | 26 | 0.030 |
Why?
| | Pedigree | 1 | 2016 | 514 | 0.030 |
Why?
| | Respiratory Mucosa | 1 | 2017 | 321 | 0.030 |
Why?
| | Gene Amplification | 1 | 2015 | 104 | 0.030 |
Why?
| | Linkage Disequilibrium | 1 | 2015 | 268 | 0.030 |
Why?
| | DNA Transposable Elements | 1 | 2015 | 119 | 0.030 |
Why?
| | Heterografts | 1 | 2014 | 138 | 0.030 |
Why?
| | Splicing Factor U2AF | 1 | 2013 | 16 | 0.030 |
Why?
| | Connectin | 1 | 2013 | 32 | 0.030 |
Why?
| | Pyrroles | 1 | 2015 | 213 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2014 | 327 | 0.030 |
Why?
| | Immunoglobulin Variable Region | 1 | 2013 | 80 | 0.030 |
Why?
| | Transcription Factor AP-2 | 1 | 2013 | 82 | 0.030 |
Why?
| | RNA, Untranslated | 1 | 2015 | 124 | 0.030 |
Why?
| | Pigmentation | 1 | 2013 | 52 | 0.030 |
Why?
| | Melanocytes | 1 | 2013 | 65 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2015 | 375 | 0.030 |
Why?
| | Piperidines | 1 | 2015 | 206 | 0.030 |
Why?
| | Cell Lineage | 1 | 2015 | 347 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2014 | 507 | 0.030 |
Why?
| | Quantitative Trait Loci | 1 | 2015 | 380 | 0.020 |
Why?
| | Mice, Nude | 1 | 2014 | 696 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 657 | 0.020 |
Why?
| | Segmental Duplications, Genomic | 1 | 2012 | 8 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2015 | 657 | 0.020 |
Why?
| | Ribonucleoproteins | 1 | 2013 | 105 | 0.020 |
Why?
| | Antineoplastic Agents | 2 | 2014 | 2122 | 0.020 |
Why?
| | Transfection | 1 | 2014 | 941 | 0.020 |
Why?
| | Down-Regulation | 1 | 2014 | 656 | 0.020 |
Why?
| | Triiodothyronine | 1 | 2012 | 43 | 0.020 |
Why?
| | Alleles | 1 | 2015 | 890 | 0.020 |
Why?
| | Pharmacogenetics | 1 | 2013 | 179 | 0.020 |
Why?
| | Fanconi Anemia | 1 | 2011 | 11 | 0.020 |
Why?
| | Chromosomal Instability | 1 | 2011 | 19 | 0.020 |
Why?
| | Checkpoint Kinase 2 | 1 | 2011 | 29 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2012 | 297 | 0.020 |
Why?
| | K562 Cells | 1 | 2011 | 89 | 0.020 |
Why?
| | Protein Stability | 1 | 2012 | 176 | 0.020 |
Why?
| | Transcription Initiation Site | 1 | 2011 | 43 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2016 | 1249 | 0.020 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2011 | 66 | 0.020 |
Why?
| | Pyrimidines | 1 | 2015 | 470 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2014 | 809 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2012 | 399 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2012 | 523 | 0.020 |
Why?
| | Autoimmunity | 1 | 2017 | 908 | 0.020 |
Why?
| | CpG Islands | 1 | 2011 | 157 | 0.020 |
Why?
| | Prostate | 1 | 2012 | 175 | 0.020 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2017 | 1090 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 3003 | 0.020 |
Why?
| | Genotype | 1 | 2015 | 1914 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4190 | 0.020 |
Why?
| | Autoantigens | 1 | 2012 | 428 | 0.020 |
Why?
| | Zebrafish | 1 | 2013 | 495 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2892 | 0.020 |
Why?
| | Tumor Suppressor Proteins | 1 | 2011 | 327 | 0.020 |
Why?
| | Female | 5 | 2016 | 72787 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2009 | 138 | 0.020 |
Why?
| | Databases, Factual | 1 | 2014 | 1351 | 0.020 |
Why?
| | DNA Damage | 1 | 2011 | 420 | 0.020 |
Why?
| | Nerve Tissue Proteins | 1 | 2012 | 595 | 0.020 |
Why?
| | Tyrphostins | 1 | 2008 | 18 | 0.020 |
Why?
| | Nucleoproteins | 1 | 2008 | 27 | 0.020 |
Why?
| | Genes, erbB-2 | 1 | 2008 | 28 | 0.020 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2008 | 30 | 0.020 |
Why?
| | Family | 1 | 2012 | 665 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 2012 | 556 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2015 | 2472 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 2011 | 613 | 0.020 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2008 | 126 | 0.020 |
Why?
| | Mesoderm | 1 | 2008 | 144 | 0.020 |
Why?
| | Disease Progression | 1 | 2014 | 2750 | 0.020 |
Why?
| | Epithelium | 1 | 2008 | 311 | 0.020 |
Why?
| | Phosphorylation | 1 | 2011 | 1758 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2009 | 378 | 0.020 |
Why?
| | DNA Helicases | 1 | 2008 | 145 | 0.020 |
Why?
| | Quinazolines | 1 | 2008 | 250 | 0.020 |
Why?
| | RNA Interference | 1 | 2008 | 466 | 0.020 |
Why?
| | Receptors, Progesterone | 1 | 2008 | 349 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2009 | 1059 | 0.020 |
Why?
| | RNA Polymerase II | 1 | 2009 | 324 | 0.010 |
Why?
| | Kinetics | 1 | 2009 | 1663 | 0.010 |
Why?
| | Receptors, Estrogen | 1 | 2008 | 436 | 0.010 |
Why?
| | Neoplasm Proteins | 1 | 2008 | 434 | 0.010 |
Why?
| | Drug Delivery Systems | 1 | 2008 | 362 | 0.010 |
Why?
| | Proteomics | 1 | 2011 | 1109 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2015 | 5735 | 0.010 |
Why?
| | Histones | 1 | 2008 | 636 | 0.010 |
Why?
| | Cell Line | 1 | 2008 | 2837 | 0.010 |
Why?
| | Protein Kinase Inhibitors | 1 | 2008 | 916 | 0.010 |
Why?
| | Protein Binding | 1 | 2008 | 2216 | 0.010 |
Why?
| | RNA | 1 | 2008 | 921 | 0.010 |
Why?
| | Signal Transduction | 1 | 2013 | 5075 | 0.010 |
Why?
| | Phenotype | 1 | 2008 | 3188 | 0.010 |
Why?
| | Young Adult | 1 | 2015 | 13129 | 0.010 |
Why?
| | Time Factors | 1 | 2009 | 6806 | 0.010 |
Why?
| | Male | 2 | 2016 | 67309 | 0.010 |
Why?
| | Middle Aged | 1 | 2015 | 33228 | 0.010 |
Why?
| | Adult | 1 | 2015 | 37630 | 0.010 |
Why?
|
|
Davis's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|